Latest Innovation News

Genetic Signatures narrowed its FY2026 net loss by 30% to $14 million amid a strategic overhaul, signing a key 10-year supply deal with Denmark’s Hvidovre Hospital and resetting its US market approach.

Prescient Therapeutics launches a $7 million Share Purchase Plan at an 18.8% discount to fund advancement of its PTX-100 cancer therapy beyond a key 2026 Dose Optimisation Committee review.

Jcurve Solutions (ASX:JCS) posted a significant financial turnaround in FY2026, with revenue climbing 16.3% to $13.28 million and normalised EBITDA more than doubling to $1.88 million, underpinned by disciplined cost control and recurring revenue growth.

XPON Technologies (ASX: XPN) posted a $1.1 million positive EBITDA in FY26 on 38% revenue growth, shedding Alpha Digital and selling its Google Marketing business to focus on its Wondaris AI platform.

Janison Education Group posted a 3% revenue rise to $48.1 million in FY26, underpinned by international contract expansion and AI innovation, despite margin pressure from onboarding costs.

Acusensus posted a 45% jump in FY26 revenue to $86.2 million, driven by major contract wins in New Zealand and the US, alongside robust domestic expansions. Despite a widened net loss due to a $16 million litigation settlement, adjusted EBITDA climbed 49%, reflecting operational momentum and strategic investments.

SkinKandy posted a strong debut full year as a listed company, growing revenue to $90.2 million and net profit to $9 million, both ahead of Prospectus expectations, driven by aggressive store expansion and robust same-store sales.

Austin Engineering's FY26 results reveal a 12.7% revenue drop and a 53.7% EBITDA decline, driven by operational setbacks in the Americas and a loss-making Chile contract. Improved cash flow and safety metrics offer a silver lining as the company embarks on a reset for FY27.

Nanosonics reported steady FY26 revenue growth driven by its trophon disinfection platform and advanced the CORIS System towards commercial launch, backed by a strong balance sheet and a new $40 million share buyback.

Beforepay Group reported a 57% jump in cash NPAT to $15.7 million for FY26, driven by strong advances growth and scaling of its Personal Loans product. The company also secured a $100 million credit facility to fuel further expansion.

Australian Ethical Investment Ltd posted record FY26 results with a 29% rise in net profit after tax and funds under management reaching $14.5 billion, driven by strong superannuation inflows and growth in private markets.

AUB Group delivered a robust FY26 with 12.2% underlying NPAT growth to $224.6 million, driven by strong international and domestic performances, and completed its strategic UK Prestige acquisition. The company declared a fully franked 71-cent final dividend and provided positive FY27 profit guidance.